No Data
Research reports on investment opportunities丨Fangzheng Securities: United Imaging Healthcare is expected to continue strong growth and is given an initial 'recommended' rating.
November 21st, Geelong ｜ Founder Securities research reports pointed out that from 2020 to 2023, United Imaging Medical (688271.SH) achieved compound revenue growth of over 25%, and compound profit growth of 30%, despite temporary performance pressure in 24Q1-3 due to domestic industry factors. With the continuous breakthrough in high-end track + growth contribution from maintenance business, the company is expected to sustain strong growth. The company is a leading domestic high-end medical imaging equipment enterprise, leveraging its leading position in the domestic industry and core strength comparable to international giants in the high-end field under the empowerment of research and innovation. With the catalyzing demand release from domestic equipment updates and overseas markets.
United Imaging Medical (688271): A leading medical imaging company driven by innovation and achieving global breakthroughs.
Investment logic: The company is a leading domestic player in the medical imaging equipment industry, innovatively empowering high-end breakthroughs and advancing globally. The company is rooted in domestic engineering advantages and has been deeply involved in medical imaging for over a decade, achieving breakthroughs in MR, computed tomography, XR, and PET/CT.
United Imaging Medical (688271): Accelerated overseas expansion, expected revenue recovery in the fourth quarter.
Investment Highlights: The company released its third quarter report for 2024, with revenue of 6.95 billion yuan in the first three quarters of 2024, a year-on-year decrease of 6.4%; net income attributable to the parent company was 0.67 billion yuan, a year-on-year decrease of 36.9%. In Q3, the company's revenue was 16 billion yuan.
Express News | 541 companies were surveyed by institutions, with shenzhen mindray bio-medical electronics being the most focused.
United Imaging Healthcare Announces Q3 2024 Results With Revenue of January to September of 6.95 Billion CNY
UNITED IMAGING(688271):ANTICIPATING A RAPID REBOUND IN DOMESTIC BUSINESS
No Data
No Data